"Moreover, the duration of follow-up is among the longest reported for a lentiviral vector-based gene therapy; 13 patients ...

The FDA cleared the launch of a Phase 1 clinical trial to test cell therapy XS-228 in people with amyotrophic lateral ...

Two small clinical trials tested the safety of injecting stem cells into the brains of Parkinson's patients and found no ...

Researchers use biocompatible polydopamine nanoparticles and near-infrared light to remotely trigger activity in neuron and ...

Steminent Biotherapeutics specializes in developing innovative stem cell-based therapeutics that offer new hope for patients ...

Mounting evidence suggests there might be two separate types of the world’s fastest-growing neurological condition. Can this ...

Abnormal kinase signaling can promote other harmful traits, such as neuroinflammation and neuronal cell death. On the other hand, the loss of function in certain kinases has been identified as a ...

AMX0114 is an antisense oligonucleotide made to prevent or slow the degeneration of axons, which is a key driver of ALS ...

If you care about Parkinson’s disease, please read studies that Vitamin B may slow down cognitive decline, and Mediterranean ...